Amid threats to his life over Covishield vaccine supplies, the CEO of Serum Institute of India, the world's largest vaccine maker, has got Y category security.
The centre granted SII CEO Adar Poonawalla enhanced security cover by the CRPF amid widespread anger over the pricing of the vaccine made by them.
#AdarPoonawalla #Covishield #SerumInstitute
The new vaccine shall be launched under the brand name of Covovax, which SII is manufacturing in partnership with US pharmaceutical firm Novovax.
Credit: DNA - Published 3 days ago
Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield..
Credit: IndiaTimes - Published 5 days ago
Novavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.
Credit: DNA - Published 6 days ago
The uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major..
Credit: IndiaTimes - Published 6 days ago